[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
uVest4u.com posts on X about stocks, nasdaq, $ci, cag the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks XXXX% finance XXXX% exchanges XXXX% cryptocurrencies XXXX%
Social topic influence stocks 1.61%, nasdaq 1.61%, $ci 1.61%, cag 0.54%, $cag 0.54%, conagra brands inc 0.54%, metrics 0.54%, $cnmd 0.54%, dow 0.54%, $anab XXXX%
Top accounts mentioned or mentioned by @zeevyinvesting
Top assets mentioned Cigna Corp (CI) Change (CAG) Conagra Brands Inc (CAG) CONMED Corporation (CNMD) ALLISON TRANSMISSION HOLDINGS, INC. (ALSN) Corcept Therapeutics Inc. (CORT) Cheniere Energy Partners, LP. (CQP) Bank of Hawaii Corp. (BOH) NextDecade Corporation Common Stock (NEXT) Amphastar Pharmaceuticals, Inc. (AMPH) Eroscoin (ERO) AppFolio, Inc. Class A (APPF)
Top posts by engagements in the last XX hours
"$CAG Conagra Brands Inc. (CAG) - Why It's Time to Sell As we delve into the financial landscape of Conagra Brands Inc. (CAG) several indicators suggest that now might be an opportune moment to consider selling this stock. Conagra Brands a significant player in the packaged food industry has faced multiple challenges recently that have negatively impacted its financial health and stock performance. According to the latest technical review from IC Markets CAG has shown considerable weakness failing to sustain any upward momentum. The stock has been unable to break through crucial resistance" @uvest4u on X 2025-06-26 20:00:17 UTC 2813 followers, XX engagements
"$CNMD Sell Recommendation for CONMED Corporation (CNMD) CONMED Corporation (CNMD) presents several red flags that suggest it might be prudent for investors to consider selling their shares. Despite the company's reputation in the medical devices sector recent market movements and financial metrics indicate potential downside risks. One of the major concerns is the company's latest quarterly earnings report which showed a decline in both revenue and profit margins. This underperformance is troubling especially when compared to the impressive growth seen in other sectors such as Electrosteel" @uvest4u on X 2025-07-19 16:00:16 UTC 2822 followers, XX engagements
"$CI CI: A Sell Opportunity Amidst Market Uncertainty and Stagnant Performance Recent analyses of the NASDAQ SP500 and Dow Jones indices indicate a general trend of stocks moving lower amidst broader market uncertainties. This trend is particularly concerning for Cigna Corporation (CI) which has shown signs of stagnation in its recent financial performance. As the markets face turbulence stocks with strong bullish forecasts and high upside potential are being favored but CI does not fall into this category. Instead it remains vulnerable to the negative sentiment surrounding the market. As seen" @uvest4u on X 2025-07-12 13:00:17 UTC 2833 followers, XX engagements
"$ANAB Analyzing ANAB: A Promising Buy Opportunity As a financial analyst I have conducted a thorough examination of AnaptysBio Inc. (NASDAQ: ANAB) and believe it presents a compelling buy opportunity based on both fundamental and technical factors. AnaptysBio is a clinical-stage biotechnology company focused on developing first-in-class antibody product candidates for inflammatory diseases. The company has shown significant progress in its pipeline particularly with its lead candidate imsidolimab which has demonstrated promising results in clinical trials for treating generalized pustular" @uvest4u on X 2025-07-15 10:00:15 UTC 2742 followers, XX engagements
"$CI Evaluating CI: A Sell Opportunity Based on Recent Trends CI known for its strong presence in the healthcare sector has recently shown signs of potential decline that warrant a closer examination. The recent headlines surrounding Thai political turmoil and economic vulnerability suggest a broader impact on global markets including the healthcare sector. CI's exposure to international markets combined with the ongoing tariff discussions as seen with the second Trump administration's policies could pose significant risks to its financial stability. The company may face challenges in" @uvest4u on X 2025-07-13 16:00:17 UTC 2833 followers, XX engagements
"$ALSN Allison Transmission Holdings Inc. (ALSN): Time to Sell Allison Transmission Holdings Inc. (ALSN) is facing several challenges that indicate it may be time to consider selling the stock. Fundamentally the company has shown signs of weakening performance. Recent financial reports highlight a decline in revenue and net income which could be attributed to the increasing competition in the automotive sector and the rising costs of raw materials. Notably other companies in the industry like Applied Materials (AMAT) with its $XXX target amid the AI memory boom are showing stronger growth" @uvest4u on X 2025-07-15 08:00:13 UTC 2769 followers, XX engagements
"$CI Sell Opportunity for CI: Fundamental and Technical Analysis The current financial outlook for CI suggests that it may be an opportune moment to consider selling. Several factors contribute to this assessment including both fundamental and technical indicators. From a fundamental perspective CI has shown signs of declining performance in recent quarters. The companys revenue growth has stagnated and profit margins have been under pressure due to increased operational costs. Additionally market conditions have become increasingly competitive which could further erode CIs market share and" @uvest4u on X 2025-07-14 10:00:15 UTC 2833 followers, XX engagements
"$CORT Buy Opportunity in Corcept Therapeutics Incorporated (CORT) Corcept Therapeutics Incorporated (CORT) is presenting a compelling buy opportunity driven by its solid fundamentals and strong technical indicators. Despite the recent decline in the stock price the fundamentals of the company remain robust. Corcept Therapeutics has consistently shown a solid financial performance with a healthy balance sheet positive cash flow and a promising pipeline of drugs. The market may be undervaluing the stock due to short-term volatility but the long-term growth potential remains intact. From a" @uvest4u on X 2025-05-27 22:00:16 UTC 2821 followers, XXX engagements
"$CQP Grifols S.A. (GRFS) - Evaluating the Sell Opportunity Grifols S.A. (GRFS) has recently been facing a challenging market environment making it a potential sell opportunity for investors. AYM Syntex's recent adjustment of its evaluation score amid mixed market sentiment highlights the volatility and uncertainty surrounding GRFS. The company's performance has been impacted by external factors including fluctuating demand in the healthcare sector and competitive pressures. Moreover the pharmaceutical industry is experiencing significant shifts with new players entering the market and" @uvest4u on X 2025-07-17 10:00:17 UTC 2852 followers, XX engagements
"$BOH Reasons to Sell Bank of Hawaii Corporation (BOH) Stock Bank of Hawaii Corporation (NYSE: BOH) has been struggling to maintain its financial health amidst the rapidly changing economic landscape making it a prime candidate for a sell recommendation. One of the primary reasons for this is the company's declining revenue growth and profitability. Over the past few quarters BOH has reported weaker-than-expected earnings reflecting the challenges posed by rising interest rates and a competitive banking environment. This is further exacerbated by the recent trend of declining loan demand which" @uvest4u on X 2025-07-16 12:00:16 UTC 2789 followers, XX engagements
"$AMRN Amarin Corporation (AMRN): A Buy Opportunity Amarin Corporation (AMRN) presents an attractive buy opportunity based on recent technical analysis and market performance indicators. According to the technical analysis scanner from Chartink AMRN has shown significant bullish momentum. The stock recently broke through key resistance levels suggesting a potential for further upside. Additionally AMRN has been forming a solid base and with the Relative Strength Index (RSI) moving away from overbought conditions it indicates a strong bullish trend continuation. Fundamentally Amarin Corporation" @uvest4u on X 2025-07-10 10:00:14 UTC 2791 followers, XXX engagements
"$NEXT Buy Opportunity for NextDecade Corporation (NEXT) NextDecade Corporation (NEXT) presents a compelling buy opportunity based on both fundamental and technical analysis. Fundamentally the company is positioned to benefit from the increasing global demand for liquefied natural gas (LNG). As of recent reports institutional investors control a significant portion of the market mirroring the pattern seen in companies like PureCycle Technologies Inc. This institutional confidence is a strong indicator of the stock's potential. Additionally the recent Mississippi-based initiatives to enhance" @uvest4u on X 2025-07-20 22:05:48 UTC 2822 followers, XXX engagements
"$AMPH Amphastar Pharmaceuticals (AMPH): A Sell Opportunity Amphastar Pharmaceuticals Inc. (NASDAQ: AMPH) presents a compelling sell opportunity based on several critical factors. Firstly the company's recent financial performance has shown signs of weakness. Despite a general uptrend in the pharmaceutical sector Amphastar's revenue growth has been lackluster and its earnings per share (EPS) have failed to meet market expectations. This underperformance is particularly concerning given the overall favorable conditions within the healthcare industry. For instance while Prologis (PLD) has" @uvest4u on X 2025-07-09 12:05:47 UTC 2769 followers, XX engagements
"$ERO Why ERO is a Sell Opportunity After thorough analysis it is clear that ERO has several red flags that make it a sell opportunity. Recent market trends and company-specific issues have contributed to this outlook. One of the critical factors influencing this recommendation is the company's recent financial performance. According to recent headlines companies such as ARC Resources Ltd. have received positive consensus ratings from analysts while ERO has not garnered similar support. This disparity suggests underlying issues within ERO that are not being addressed effectively impacting" @uvest4u on X 2025-07-16 14:00:15 UTC 2756 followers, XX engagements
"Kabushiki Kaisha (TSE:9101) Watsco Q2 Preview: A2L Refrigerant Transition Is A . - Seeking Alpha Are Bossard Holding AG's (VTX:BOSN) Fundamentals Good Enough to Warrant . KeyBanc downgrades Federal Signal stock as shares reach premium . Macquaries Influence on ASX XXX Mining Stock Investments $APPF #StockMarket #Stocks #Markets #DowJones #Finance #StocksToWatch #Bullish #Bearish #Economy #Money #Investing #Currency #Commodities #Crypto #News" @uvest4u on X 2025-07-11 14:00:25 UTC 2853 followers, 4693 engagements